$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Pharmaceutically acceptable salts 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-211/86
  • A61K-031/455
출원번호 US-0256938 (1988-10-13)
우선권정보 GB-0008335 (1986-04-04)
발명자 / 주소
  • Davison Edward (Margate GB2) Wells James I. (Canterbury GB2)
출원인 / 주소
  • Pfizer Inc. (New York NY 02)
인용정보 피인용 횟수 : 98  인용 특허 : 1

초록

Improved pharmaceutical salts of amlodipine, particularly the besylate salt, and pharmaceutical compositions thereof. These salts find utility as anti-ischaemic and anti-hypertensive agents.

대표청구항

The besylate salt of amlodipine.

이 특허에 인용된 특허 (1)

  1. Spiegel Rene (Basel NJ CH) Gogerty John H. (Randolph Township NJ) Loew Dieter M. (Bottmingen NJ CH) Eden Phillip L. (Whippany NJ), Method of promoting sleep.

이 특허를 인용한 특허 (98)

  1. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Baevsky, Matthew F.; Singh, Juswinder, 2,4-disubstituted pyrimidine compounds useful as kinase inhibtors.
  2. Singh, Juswinder; Petter, Russell; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, III, William Frederick; Niu, Deqiang; Qiao, Lixin, 2,4-disubstituted pyrimidines as kinase inhibitors.
  3. Singh, Juswinder; Petter, Russell C.; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, III, William Frederick; Niu, Deqiang; Qiao, Lixin, 2,4-disubstituted pyrimidines useful as kinase inhibitors.
  4. Lemmens, Jacobus M.; Peters, Theodorus H. A.; Benneker, Franciscus B. G., Amide derivative of amlodipine.
  5. Lemmens,Jacobus M.; Peters,Theodorus H. A.; Benneker,Franciscus B. G., Amide derivative of amlodipine.
  6. Lemmens,Jacobus M.; Peters,Theodorus H. A.; Benneker,Franciscus B. G., Amide derivative of amlodipine.
  7. Lemmens,Jacobus M.; Peters,Theodorus H. A.; Benneker,Franciscus B. G.; Keltjens,Rolf, Amlodipine free base.
  8. Lemmens, Jacobus M.; Peters, Theodorus H. A.; Benneker, Franciscus B. G.; Picha, Frantisek, Amlodipine fumarate.
  9. Ettema, Gerrit J. B., Amlodipine hemimaleate.
  10. Ettema, Gerrit J. B.; Hoorn, Hans; Lemmens, Jacobus M., Amlodipine salt forms and processes for preparing them.
  11. Jacobus M. Lemmens NL; Theodorus H. A. Peters NL; Franciscus B. G. Benneker NL, Aspartate derivative of amlodipine.
  12. Witowski, Steven Richard; Westlin, III, William Frederick; Tester, Richland Wayne, Besylate salt of a BTK inhibitor.
  13. Witowski, Steven Richard; Westlin, III, William Frederick; Tester, Richland Wayne, Besylate salt of a BTK inhibitor.
  14. Cropp Anne B. ; Kraska Allen R., Composition containing amlodipine or a pharmaceutically acceptable salt thereof, and an ACE inhibitor.
  15. Lim,Dong Kwon; Lee,Hyuk Koo; Suh,Hea Ran; Cho,Seong Hwan; Lee,Kwang Hyeg; Kim,Yun Cheul; Jung,Sung Hak; Lee,Sung Hak; Kang,Hyun Suk; Park,Kyung Mi; Jung,Yun Taek; Cheon,Jun Hee; Park,Choong Sil; Youn, Crystalline organic acid salt of amlodipine.
  16. Haq, Nadia; Niu, Deqiang; Petter, Russell C.; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong, ERK inhibitors and uses thereof.
  17. Haq, Nadia; Niu, Deqiang; Petter, Russell C.; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong, ERK inhibitors and uses thereof.
  18. Haq, Nadia; Niu, Deqiang; Petter, Russell C.; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong, ERK inhibitors and uses thereof.
  19. Haq, Nadia; Niu, Deqiang; Petter, Russell C.; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong, ERK inhibitors and uses thereof.
  20. Haq, Nadia; Niu, Deqiang; Petter, Russell C.; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong, ERK inhibitors and uses thereof.
  21. Ferretti, Antonio Christian; Huang, Lianfeng; Li, Ying; Traverse, John; Xu, Jean; Yong, Kelvin Hin-Yeong; Zou, Daozhong, Forms and compositions of an ERK inhibitor.
  22. Ferretti, Antonio Christian; Huang, Lianfeng; Li, Ying; Traverse, John; Xu, Jean; Yong, Kelvin Hin-Yeong; Zou, Daozhong, Forms and compositions of an ERK inhibitor.
  23. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Singh, Juswinder, Heteroaryl compounds and uses thereof.
  24. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Singh, Juswinder, Heteroaryl compounds and uses thereof.
  25. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Singh, Juswinder, Heteroaryl compounds and uses thereof.
  26. Tester, Richland; Chaturvedi, Prasoon; Zhu, Zhendong; Surapaneni, Sekhar S.; Beebe, Lisa, Heteroaryl compounds and uses thereof.
  27. Tester, Richland; Chaturvedi, Prasoon; Zhu, Zhendong; Surapaneni, Sekhar S.; Beebe, Lisa, Heteroaryl compounds and uses thereof.
  28. Tester, Richland; Chaturvedi, Prasoon; Zhu, Zhendong; Surapaneni, Sekhar S.; Beebe, Lisa, Heteroaryl compounds and uses thereof.
  29. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Baevsky, Matthew F.; Singh, Juswinder, Heterocyclic compounds and uses thereof.
  30. Lee, Kwangho; Niu, Deqiang; Petter, Russell C.; Baevsky, Matthew Frank; Singh, Juswinder, Heterocyclic compounds and uses thereof.
  31. Furlan,Borut; Resnik,Marijan, High purity amlodipine benzenesulfonate and a process for its preparation.
  32. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use.
  33. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat, Levodopa prodrug mesylate hydrate.
  34. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat R., Levodopa prodrug mesylate hydrate.
  35. Milne ; Jr. George M. (Niantic CT) Wyllie Michael G. (Canterbury GB2), Method of treating impotence.
  36. Foster Robert T.,CAX, Method of using deuterated calcium channel blockers.
  37. Yoo, Seo Hong, Methods and compositions for reducing toxicity of a pharmaceutical compound.
  38. Young James W., Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine.
  39. Stover, Robert Carl, Methods and formulations for treating ineffective or decreased esophagal motility.
  40. James W. Young, Methods for treating hypertension and angina using salts of optically pure (-) amplodipine.
  41. Young James W., Methods for treating hypertension, and angina using optically pure (-) amlodipine.
  42. Young, James W., Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine.
  43. Raillard, Stephen P.; Mann, Adam; Manthati, Suresh K.; Scheuerman, Randall A.; Estrada, Tono; Nguyen, Mark Q.; Zhou, Cindy X, Methods of synthesizing a levodopa ester prodrug.
  44. Witowski, Steven Richard; Westlin, III, William Frederick; Lounsbury, Heather; Stiede, Kathryn; Silver, Bruce A.; Mei, Jay M., Methods of treating a Bruton's Tyrosine Kinase disease or disorder.
  45. Daniel, Tom; Takeshita, Kenichi; Foon, Kenneth; Mei, Jay, Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase.
  46. Lee, Kwangho; Niu, Deqiang; Baevsky, Matthew F., Mutant-selective EGFR inhibitors and uses thereof.
  47. Lee, Kwangho; Niu, Deqiang; Baevsky, Matthew Frank, Mutant-selective EGFR inhibitors and uses thereof.
  48. George Chang ; Ernest S. Hamanaka ; John L. LaMattina, Mutual prodrugs of amlodipine and atorvastatin.
  49. Chang George ; Hamanaka Ernest S., Mutual salt of amlodipine and atorvastatin.
  50. Kim, Sung Wuk; Jun, Sung Soo; Jo, Young Gwan; Koo, Ja Seong; Kim, Young Woong, N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same.
  51. Kim, Sung Wuk; Jun, Sung Soo; Jo, Young Gwan; Koo, Ja Seong; Kim, Young Woong, N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same.
  52. Kim, Sung Wuk; Jun, Sung Soo; Jo, Young Gwan; Koo, Ja Seong; Kim, Young Woong; Kim, Byoung Ha; Kim, Duck, N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same.
  53. Yoo, Seo Hong, Neuroprotective effect of solubilized UDCA in focal ischemic model.
  54. Ren, Zhongxu; Deng, Bo-Liang; Riggs-Sauthier, Jennifer; Harvey, Micah, Oligomer-calcium channel blocker conjugates.
  55. May, Donald F.; Rains, Jr., Jack C., Optical integrating cavity lighting system using multiple LED light sources.
  56. James W. Young, Optically pure (-) amlodipine compositions.
  57. Cho, Seong Hwan; Youn, Yong Sik; Jung, Yun Taek; Park, Choong Sil; Lee, Hyuk Koo; Lee, Kwang Hyeg; Jeong, Eun Ju; Kim, Young Hoon; Jin, Hae Tak; Cheon, Jun Hee; Lee, Sung Hak; Jung, Sung Hak; Lim, Do, Organic acid salt of amlodipine.
  58. Cho, Seong Hwan; Youn, Yong Sik; Jung, Yun Taek; Park, Choong Sil; Lee, Hyuk Koo; Lee, Kwang Hyeg; Jeong, Eun Ju; Kim, Young Hoon; Jin, Hae Tak; Cheon, Jun Hee; Lee, Sung Hak; Jung, Sung Hak; Lim, Do, Organic acid salt of amlodipine.
  59. Cho, Seong Hwan; Youn, Yong Sik; Jung, Yun Taek; Park, Choong Sil; Lee, Hyuk Koo; Lee, Kwang Hyeg; Jeong, Eun Ju; Kim, Young Hoon; Jin, Hae Tak; Cheon, Jun Hee; Lee, Sung Hak; Jung, Sung Hak; Lim, Do, Organic acid salt of amlodipine.
  60. Youn, Yong Sik; Cho, Seong Hwan; Park, Choong Sil; Kim, Yun Cheul; Lim, Dong Kwon; Jung, Sung Hak; Lee, Sung Hak; Kang, Hyun Suk; Park, Kyung Mi; Jung, Yun Taek; Kim, Young Hoon; Yeon, Kyu Jeong; Cha, Organic acid salt of amlodipine.
  61. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  62. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  63. Mao, Chen; Pargaonkar, Nikhil; Maurer, Laura E.; Ma, Sarina Grace Harris, Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use.
  64. Lemmens, Jacobus M.; van Dalen, Frans; Vanderheijden, Arlette, Pharmaceutical compositions comprising amlodipine maleate.
  65. Kute, Anirudha Bhagirath; Malewar, Nikhil Prabhakar; Avachat, Makarand Krishnakumar, Pharmaceutical compositions of amlodipine and valsartan.
  66. Lee, Fang Yu; Huang, Tsang-Miao; Chung, Chao-Ho, Pharmaceutically acceptable salt of amlodipine and method of preparing the same.
  67. Lee,Fang Yu; Chen,Shan Chiung; Chen,Bin Ken; Tsai,Chiung Ju; Yi,Yen Ling, Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same.
  68. Yoo,Seo Hong, Preparation of aqueous clear solution dosage forms with bile acids.
  69. Kaul, Vijay; Yadav, Gyan Chand, Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt.
  70. Peters, Theodorus H. A.; Benneker, Franciscus B. G.; Slanina, Pavel; Bartl, Jiri, Process for making amlodipine.
  71. Benneker, Franciscus B. G.; Slanina, Pavel; Picha, Frantisek, Process for making amlodipine maleate.
  72. Peters, Theodorus H. A.; Benneker, Franciscus B. G.; Slanina, Pavel; Bartl, Jiri, Process for making amlodipine, derivatives thereof, and precursors therefor.
  73. Sattigeri, Jitendra Anant; Sethi, Sachin; Kishore, Kaushal, Process for preparation of (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt.
  74. Bozsing Daniel,HUX ; Kovanyi Gyorgyi Lax,HUX ; Simig Gyula,HUX ; Krasznai Gyorgy,HUX ; Blasko Gabor,HUX ; Tompe Peter,HUX ; Nagy Kalman,HUX ; Vereczkey Gyorgyi Donath,HUX ; Nemei Gabor,HUX ; Nemeth N, Process for the preparation of a dihydropyridine derivative.
  75. Purohit, Arun Kumar; Desai, Brahmader Chilu; Shete, Balasaheb Dashrath; Bagwan, Salim Abbas, Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate.
  76. Pfefferkorn,Jeffrey A., Pyrazole-based HMG CoA reductase inhibitors.
  77. Lockhart,David J.; Patel,Hitesh K.; Milanov,Zdravko V.; Mehta,Shamal Anil; Zarrinkar,Patrick Parvis; Biggs, III,William H.; Ciceri,Pietro; Fabian,Miles A.; Treiber,Daniel K., Pyrrole compounds and uses thereof.
  78. Lemmens, Jacobus M; Peters, Theodorus H. A.; Bakker, Peter F. A.; Picha, Frantisek, Reference standards for determining the purity or stability of amlodipine maleate and processes therefor.
  79. Chung, You Sup; Ha, Mun Choun, S-(-)-amlodipine nicotinate and process for the preparation thereof.
  80. Chung,You Sup; Ha,Mun Choun, S-(-)-amlodipine nicotinate and process for the preparation thereof.
  81. Basford, Patricia Ann; Campeta, Anthony Michael; Gillmore, Adam; Jones, Matthew Cameron; Kougoulos, Eleftherios; Luthra, Suman; Walton, Robert, Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one.
  82. Lai, Mei; Witowski, Steven Richard; Tester, Richland Wayne; Lee, Kwangho, Salts of an epidermal growth factor receptor kinase inhibitor.
  83. Lai, Mei; Witowski, Steven Richard; Tester, Richland Wayne; Lee, Kwangho, Salts of an epidermal growth factor receptor kinase inhibitor.
  84. Lai, Mei; Witowski, Steven Richard; Tester, Richland Wayne; Lee, Kwangho, Salts of an epidermal growth factor receptor kinase inhibitor.
  85. Lai, Mei, Solid forms of an epidermal growth factor receptor kinase inhibitor.
  86. Lai, Mei, Solid forms of an epidermal growth factor receptor kinase inhibitor.
  87. Lai, Mei, Solid forms of an epidermal growth factor receptor kinase inhibitor.
  88. Singh, Juswinder; Petter, Russell C.; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, III, William Frederick; Niu, Deqiang; Qiao, Lixin, Substituted 2,4-diaminopyrimidines as kinase inhibitors.
  89. Singh, Juswinder; Petter, Russell C.; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, III, William Frederick; Niu, Deqiang; Qiao, Lixin, Substituted 2,4-diaminopyrimidines as kinase inhibitors.
  90. Singh, Juswinder; Petter, Russell C.; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, III, William Frederick; Niu, Deqiang; Qiao, Lixin, Substituted 2,4-diaminopyrimidines as kinase inhibitors.
  91. Buxton,Philip Christopher; Mackenzie,Donald Colin, Substituted thiazolidinedione derivatives.
  92. Papa Joseph,CHX ; Henis Marc M. J., Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor.
  93. Mason, R. Preston, Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release.
  94. Mason,R. Preston, Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy.
  95. Jan Buch, Therapeutic combination.
  96. Foster, Adrian Paul, Treatment of renal disorders.
  97. Leamon, Christopher P.; Parker, Matthew A., Vitamin-targeted imaging agents.
  98. Leamon, Christopher P.; Parker, Matthew A., Vitamin-targeted imaging agents.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로